Skip to main content

Table 6 Analysis of marketed formulation

From: Stability-indicating HPLC-DAD method for the determination of empagliflozin

Marketed formulation Recovered amount Claimed amount (mg)
Amount found (mg) Recovery(%) ± SD* RSD* (%)
Formulation 1 (Empagliflozin 25 mg, excipients qs) 24.97 99.90 ± 0.258 0.258 25
Formulation 2 (Empagliflozin 25 mg, excipients qs) 24.98 99.94 ± 0.240 0.240 25
  1. *Average of three determinations of three different concentration